本レポートは、力強い成長を経験しているがんモノクローナル抗体市場に焦点を当てています。今後10年以上にわたって私たちの生活を形作り変化させるがんモノクローナル抗体市場へのガイドを提供します。
目次
Table of Contents
1. Executive Summary
2. Cancer Monoclonal Antibodies Market Characteristics
3. Cancer Monoclonal Antibodies Market Trends And Strategies
4. Cancer Monoclonal Antibodies Market - Macro Economic Scenario
4.1 COVID - 19 Impact On Cancer Monoclonal Antibodies Market
4.2 Ukraine - Russia War Impact On Cancer Monoclonal Antibodies Market
4.3 Impact Of High Inflation On Cancer Monoclonal Antibodies Market
5. Cancer Monoclonal Antibodies Market Size And Growth
5.1. Global Cancer Monoclonal Antibodies Historic Market, 2017 - 2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Cancer Monoclonal Antibodies Forecast Market, 2022 - 2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Cancer Monoclonal Antibodies Market Segmentation
6.1. Global Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Bevacizumab (Avastin)
Rituximab (Rituxan)
Trastuzumab (Herceptin)
Cetuximab (Erbitux)
Panitumumab (Vectibix)
Others
6.2. Global Cancer Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Breast Cancer
Blood Cancer
Liver Cancer
Brain Cancer
Colorectal Cancer
Others
6.3. Global Cancer Monoclonal Antibodies Market, Segmentation By End User, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Hospitals and Clinics
Research Laboratories
Pharmacies
Others
7. Cancer Monoclonal Antibodies Market Regional And Country Analysis
7.1. Global Cancer Monoclonal Antibodies Market, Split By Region, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
7.2. Global Cancer Monoclonal Antibodies Market, Split By Country, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
8. Asia - Pacific Cancer Monoclonal Antibodies Market
8.1. Asia - Pacific Cancer Monoclonal Antibodies Market Overview
Region Information, Impact Of COVID - 19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia - Pacific Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
9. China Cancer Monoclonal Antibodies Market
9.1. China Cancer Monoclonal Antibodies Market Overview
9.2. China Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F,$ Billion
10. India Cancer Monoclonal Antibodies Market
10.1. India Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
11. Japan Cancer Monoclonal Antibodies Market
11.1. Japan Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
12. Australia Cancer Monoclonal Antibodies Market
12.1. Australia Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
13. Indonesia Cancer Monoclonal Antibodies Market
13.1. Indonesia Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
14. South Korea Cancer Monoclonal Antibodies Market
14.1. South Korea Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
15. Western Europe Cancer Monoclonal Antibodies Market
15.1. Western Europe Cancer Monoclonal Antibodies Market Overview
15.2. Western Europe Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
16. UK Cancer Monoclonal Antibodies Market
16.1. UK Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
17. Germany Cancer Monoclonal Antibodies Market
17.1. Germany Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
18. France Cancer Monoclonal Antibodies Market
18.1. France Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
19. Eastern Europe Cancer Monoclonal Antibodies Market
19.1. Eastern Europe Cancer Monoclonal Antibodies Market Overview
19.2. Eastern Europe Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
20. Russia Cancer Monoclonal Antibodies Market
20.1. Russia Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
21. North America Cancer Monoclonal Antibodies Market
21.1. North America Cancer Monoclonal Antibodies Market Overview
21.2. North America Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
22. USA Cancer Monoclonal Antibodies Market
22.1. USA Cancer Monoclonal Antibodies Market Overview
22.2. USA Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
23. South America Cancer Monoclonal Antibodies Market
23.1. South America Cancer Monoclonal Antibodies Market Overview
23.2. South America Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
24. Brazil Cancer Monoclonal Antibodies Market
24.1. Brazil Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
25. Middle East Cancer Monoclonal Antibodies Market
25.1. Middle East Cancer Monoclonal Antibodies Market Overview
25.2. Middle East Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
26. Africa Cancer Monoclonal Antibodies Market
26.1. Africa Cancer Monoclonal Antibodies Market Overview
26.2. Africa Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
27. Cancer Monoclonal Antibodies Market Competitive Landscape And Company Profiles
27.1. Cancer Monoclonal Antibodies Market Competitive Landscape
27.2. Cancer Monoclonal Antibodies Market Company Profiles
27.2.1. Amgen
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Bristol Myers Squibb Company
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Eli Lilly and Company
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. F. Hoffmann - La Roche Ltd
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Genmab AS
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Cancer Monoclonal Antibodies Pipeline Analysis
29. Key Mergers And Acquisitions In The Cancer Monoclonal Antibodies Market
30. Cancer Monoclonal Antibodies Market Future Outlook and Potential Analysis
31. Appendix
31.1. Abbreviations
31.2. Currencies
31.3. Historic And Forecast Inflation Rates
31.4. Research Inquiries
31.5. The Business Research Company
31.6. Copyright And Disclaimer
List of Tables
Table 1: Global Historic Market Growth, 2017 - 2022, $ Billion
Table 2: Global Forecast Market Growth, 2022 - 2027F, 2032F, $ Billion
Table 3: Global Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 4: Global Cancer Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 5: Global Cancer Monoclonal Antibodies Market, Segmentation By End User, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 6: Global Cancer Monoclonal Antibodies Market, Split By Region, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 7: Global Cancer Monoclonal Antibodies Market, Split By Country, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 8: Asia - Pacific, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 9: China, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 10: India, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 11: Japan, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 12: Australia, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 13: Indonesia, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 14: South Korea, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 15: Western Europe, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 16: UK, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 17: Germany, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 18: France, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 19: Eastern Europe, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 20: Russia, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 21: North America, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 22: USA, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 23: South America, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 24: Brazil, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 25: Middle East, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 26: Africa, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 27: Amgen Financial Performance
Table 28: Bristol Myers Squibb Company Financial Performance
Table 29: Eli Lilly and Company Financial Performance
Table 30: F. Hoffmann - La Roche Ltd Financial Performance
Table 31: Genmab AS Financial Performance
List of Figures
Figure 1: Global Historic Market Growth, 2017 - 2022, $ Billion
Figure 2: Global Forecast Market Growth, 2022 - 2027F, 2032F, $ Billion
Figure 3: Global Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 4: Global Cancer Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 5: Global Cancer Monoclonal Antibodies Market, Segmentation By End User, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 6: Global Cancer Monoclonal Antibodies Market, Split By Region, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 7: Global Cancer Monoclonal Antibodies Market, Split By Country, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 8: Asia - Pacific, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 9: China, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 10: India, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 11: Japan, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 12: Australia, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 13: Indonesia, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 14: South Korea, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 15: Western Europe, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 16: UK, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 17: Germany, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 18: France, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 19: Eastern Europe, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 20: Russia, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 21: North America, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 22: USA, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 23: South America, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 24: Brazil, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 25: Middle East, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 26: Africa, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 27: Amgen Financial Performance
Figure 28: Bristol Myers Squibb Company Financial Performance
Figure 29: Eli Lilly and Company Financial Performance
Figure 30: F. Hoffmann - La Roche Ltd Financial Performance
Figure 31: Genmab AS Financial Performance
